Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology

Journal of Molecular Diagnostics

Volumn 7, Issue 4, 2005, Pages 517-524

  Woenckhaus, Matthias ^a   Grepmeier, Ulrike ^a   Werner, Bernhard ^b   Schulz, Christian ^a   Rockmann, Felix ^b   Wild, Peter J ^a   Röckelein, Georg ^c   Blaszyk, Hagen ^d   Schuierer, Marion ^a   Hofstaedter, Ferdinand ^a   Hartmann, Arndt ^a   Dietmaier, Wolfgang ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Donaustauf Hospital   (Germany)

^c Institute for Pathology   (Germany)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOMAL LOCALIZATION; CLINICAL ARTICLE; CYTOLOGY; DIAGNOSTIC PROCEDURE; FEMALE; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG CANCER; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; PLEURA EFFUSION; PLEURA FLUID; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SUPERNATANT;

EID: 26944463874     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60583-1     Document Type: Article

References (73)

1. Chapman SJ, Davies RJ: Pleural effusions. Clin Med 2004, 4:207-210
2. Light RW: Diagnostic principles in pleural disease. Eur Respir J 1997, 10:476-481
3. Reithineier A, Lydtin H: Pleural effusion. Internist (Berl) 1996, 37:959-968
4. Garcia-Bonafe M, Moragas A: Differential diagnosis of malignant and reactive cells from serous effusions: image and texture analysis study. Anal Cell Pathol 1996, 12:85-98
5. Kjellberg SI, Dresler CM, Goldberg M: Pleural cytologies in lung cancer without pleural effusions. Ann Thorac Surg 1997, 64:941-944
6. Martensson G, Pettersson K, Thiringer G: Differentiation between malignant and non-malignant pleural effusion. Eur J Respir Dis 1985, 67:326-334
7. Nance KV, Shermer RW, Askin FB: Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination. Mod Pathol 1991, 4:320-324
8. Motherby H, Nadjari B, Friegel P, Kohaus J, Ramp U, Bocking A: Diagnostic accuracy of effusion cytology. Diagn Cytopathol 1999, 20:350-357
9. Ahrendt SA, Sidransky D: The potential of molecular screening. Surg Oncol Clin N Am 1999, 8:641-656
10. Davidson B: Malignant effusions: from diagnosis to biology. Diagn Cytopathol 2004, 31:246-254
11. Musilova J, Michalova K: Cytogenetic study of cancer cells in effusions. Cancer Genet Cytogenet 1986, 19:271-279
12. Motherby H, Pomjanski N, Kube M, Boros A, Heiden T, Tribukait B, Bocking A: Diagnostic DNA-flow- vs. -image-cytometry in effusion cytology. Anal Cell Pathol 2002, 24:5-15
13. Motherby H, Kube M, Friedrichs N, Nadjari B, Knops K, Donner A, Baschiera B, Dalquen P, Bocking A: Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology I. Prevalence of markers in tumour cell positive and negative smears. Anal Cell Pathol 1999, 19:7-20
14. Fiegl M, Kaufmann H, Zojer N, Schuster R, Wiener H, Mullauer L, Roka S, Huber H, Drach J: Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma. Hum Pathol 2000, 31:448-455
15. Yu CJ, Shew JY, Liaw YS, Kuo SH, Luh KT, Yang PC: Application of mucin quantitative competitive reverse transcription polymerase chain reaction in assisting the diagnosis of malignant pleural effusion. Am J Respir Crit Care Med 2001, 164:1312-1318
16. Braunschweig R, Guilleret I, Delacretaz F, Bosman FT, Mihaescu A, Benhattar J: Pitfalls in TRAP assay in routine detection of malignancy in effusions. Diagn Cytopathol 2001, 25:225-230
17. Ahrendt SA, Chow JT, Yang SC, Wu L, Zhang MJ, Jen J, Sidransky D: Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Res 2000, 60:3155-3159
18. Hu Y, McDermott MP, Ahrendt SA: The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer. Clin Cancer Res 2005, 11:2502-2509
19. Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, Herman JG, Wu L, Decker PA, Jen J, Sidransky D: Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 1999, 91:332-339
20. Dahl C, Guldberg P: DNA methylation analysis techniques. Biogerontology 2003, 4:233-250
21. Janne PA, Li C, Zhao X, Girard L, Chen TH, Minna J, Christiani DC, Johnson BE, Meyerson M: High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines. Oncogene 2004, 23:2716-2726
22. Ahrendt SA, Decker PA, Doffek K, Wang B, Xu L, Demeure MJ, Jen J, Sidransky D: Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in non-small cell lung cancer. Cancer Res 2000, 60:2488-2491
23. Xu L, Chow J, Bonacum J, Eisenberger C, Ahrendt SA, Spafford M, Wu L, Lee SM, Piantadosi S, Tockman MS, Sidransky D, Jen J: Microsatellite instability at AAAG repeat sequences in respiratory tract cancers. Int J Cancer 2001, 91:200-204
24. Singer G, Kallinowski T, Hartmann A, Dietmaier W, Wild PJ, Schraml P, Sauter G, Mihatsch MJ, Moch H: Different types of microsatellite instability in ovarian carcinoma. Int J Cancer 2004, 112:643-646
25. Woenckhaus M, Stoehr R, Dietmaier W, Wild PJ, Zieglmeier U, Foerster J, Merk J, Blaszyk H, Pfeifer M, Hofstaedter F, Hartmann A: Microsatellite instability at chromosome 8p in non-small cell lung cancer is associated with lymph node metastasis and squamous differentiation. Int J Oncol 2003, 23:1357-1363
26. Sidransky D: Emerging molecular markers of cancer. Nat Rev Cancer 2002, 2:210-219
27. Dietmaier W, Hartmann A, Wallinger S, Heinmoller E, Kerner T, Endl E, Jauch KW, Hofstadter F, Ruschoff J: Multiple mutation analyses in single tumor cells with improved whole genome amplification. Am J Pathol 1999, 154:83-95
28. Stoehr R, Wild P, Hartmann A: Lasermicrodissection: an important prerequisite for the molecular-genetic analysis of bladder cancer. Pathol Res Pract 2003, 199:355-362
29. Lee JH, Hong YS, Ryu JS, Chang JH: p53 and FHIT mutations and microsatellite alterations in malignancy-associated pleural effusion. Lung Cancer 2004, 44:33-42
30. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D: Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996, 2:1035-1037
31. Sanchez-Cespedes M, Monzo M, Rosell R, Pifarre A, Calvo R, Lopez-Cabrerizo MP, Astudillo J: Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. Ann Oncol 1998, 9:113-116
32. Chen X, Bonnefoi H, Diebold-Berger S, Lyautey J, Lederrey C, Faltin-Traub E, Stroun M, Anker P: Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res 1999, 5:2297-2303
33. Anker P, Mulcahy H, Chen XQ, Stroun M: Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 1999, 18:65-73
34. Ang P, Tan EH, Leong SS, Koh L, Eng P, Agasthian T, Cheah FK: Primary intrathoracic malignant effusion: a descriptive study. Chest 2001, 120:50-54
35. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J: Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997, 57:4749-4756
36. Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD, Gazdar AF: Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999, 18:643-650
37. Sozzi G, Conte D, Mariani L, Lo Vullo S, Roz L, Lombardo C, Pierotti MA, Tavecchio L: Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001, 61:4675-4678
38. Ahmed M, Giles F, Joe Y, Weber DM, Jilani I, Manshouri T, Giralt S, De Lima M, Keating M, Albitar M: Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma. Eur J Haematol 2003, 71:174-178
39. Braga E, Senchenko V, Bazov I, Loginov W, Liu J, Ermilova V, Kazubskaya T, Garkavtseva R, Mazurenko N, Kisseljov F, Lerman MI, Klein G, Kisselev L, Zabarovsky ER: Critical tumor-suppressor gene regions on chromosome 3P in major human epithelial malignancies: allelotyping and quantitative real-time PCR. Int J Cancer 2002, 100:534-541
40. Miyaki M, Seki M, Okamoto M, Yamanaka A, Maeda Y, Tanaka K, Kikuchi R, Iwama T, Ikeuchi T, Tonomura A: Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 1990, 50:7166-7173
41. Sanz-Ortega J, Valor C, Saez MC, Ortega L, Sierra E, Poch J, Hernandez S, Sanz-Esponera J: 3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation. Histol Histopathol 2003, 18:1053-1057
42. Tsuji N, Furuse K, Asanuma K, Furuya M, Kondoh K, Kamagata C, Sasaki M, Kobayashi D, Yagihashi A, Takahashi H, Watanabe N: Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer. Breast Cancer Res Treat 2004, 87:23-31
43. Kohno H, Hiroshima K, Toyozaki T, Fujisawa T, Ohwada H: p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma. Cancer 1999, 85:341-347
44. Matsumoto S, Kasumi F, Sakamoto G, Onda M, Nakamura Y, Emi M: Detailed deletion mapping of chromosome arm 3p in breast cancers: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors. Genes Chromosomes Cancer 1997, 20:268-274
45. Wistuba II, Thomas B, Behrens C, Onuki N, Lindberg G, Albores-Saavedra J, Gazdar AF: Molecular abnormalities associated with endocrine tumors of the uterine cervix. Gynecol Oncol 1999, 72:3-9
46. Sanz-Ortega J, Sanz-Esponera J, Caldes T, Gomez de la Concha E, Sobel ME, Merino MJ: LOH at the APC/MCC gene (5Q21) in gastric cancer and preneoplastic lesions: prognostic implications. Pathol Res Pract 1996, 192:1206-1210
47. Huang JS, Chiang CP, Kok SH, Kuo YS, Kuo MY: Loss of heterozygosity of APC and MCC genes in oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1997, 26:322-326
48. Davidson B, Risberg B, Reich R, Berner A: Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis. Clin Lab Med 2003, 23:729-754
49. Davidson B, Reich R, Lazarovici P, Ann Florenes V, Nielsen S, Nesland JM: Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Res Treat 2004, 83:119-128
50. Grunewald K, Haun M, Fiegl M, Urbanek M, Muller-Holzner E, Massoner A, Riha K, Propst A, Marth C, Gastl G: Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction. Lab Invest 2002, 82:1147-1153
51. Patel IS, Madan P, Getsios S, Bertrand MA, MacCalman CD: Cadherin switching in ovarian cancer progression. Int J Cancer 2003, 106:172-177
52. Dai Y, Morishita Y, Mase K, Sato N, Akaogi E, Mitsui T, Noguchi M: Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas. Cancer 2000, 90:258-263
53. de Matos Granja N, Soares R, Rocha S, Paredes J, Longatto Filho A, Alves VA, Wiley E, Schmitt FC, Bedrossian C: Evaluation of breast cancer metastases in pleural effusions by molecular biology techniques. Diagn Cytopathol 2002, 27:210-213
54. Davidson B, Konstantinovsky S, Nielsen S, Dong HP, Berner A, Vyberg M, Reich R: Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression. Clin Cancer Res 2004, 10:7335-7346
55. Elloul S, Bukholt Elstrand M, Nesland JM, Trope CG, Kvalheim G, Goldberg I, Reich R, Davidson B: Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 2005, 103:1631-1643
56. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA: Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000, 60:5954-5958
57. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE: Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002, 62:2370-2377
58. Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindan J: Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Cancer 2001, 93:68-72
59. Fetsch PA, Abati A: Immunocytochemistry in effusion cytology: a contemporary review. Cancer 2001, 93:293-308
60. Goessl C, Muller M, Straub B, Miller K: DNA alterations in body fluids as molecular tumor markers for urological malignancies. Eur Urol 2002, 41:668-676
61. Eisenberger CF, Schoenberg M, Enger C, Hortopan S, Shah S, Chow NH, Marshall FF, Sidransky D: Diagnosis of renal cancer by molecular urinalysis. J Natl Cancer Inst 1999, 91:2028-2032
62. Utting M, Werner W, Dahse R, Schubert J, Junker K: Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. Clin Cancer Res 2002, 8:35-40
63. Wang Y, Yamaguchi Y, Watanabe H, Ohtsubo K, Wakabayashi T, Sawabu N: Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation, J Gastroenterol 2002, 37:831-839
64. Wang Y, Yamaguchi Y, Watanabe H, Ohtsubo K, Motoo Y, Sawabu N: Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas. Pancreas 2004, 28:13-19
65. Nawroz-Danish H, Eisenberger CF, Yoo GH, Wu L, Koch W, Black C, Ensley JF, Wei WZ, Sidransky D: Microsatellite analysis of serum DNA in patients with head and neck cancer. Int J Cancer 2004, 111:96-100
66. Coulet F, Blons H, Cabelguenne A, Lecomte T, Lacourreye O, Brasnu D, Beaune P, Zucman J, Laurent-Puig P: Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res 2000, 60:707-711
67. Wang Y, Hung SC, Linn JF, Steiner G, Glazer AN, Sidransky D, Mathies RA: Microsatellite-based cancer detection using capillary array electrophoresis and energy-transfer fluorescent primers. Electrophoresis 1997, 18:1742-1749
68. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, Samet JM, Srivastava S, Minna JD, Gazdar AF: Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997, 89:1366-1373
69. Piard F, Martin L, Chapusot C, Ponnelle T, Faivre J: Genetic pathways in colorectal cancer: interest for the pathologist. Ann Pathol 2002, 22:277-288
70. Dolan K, Garde J, Walker SJ, Sutton R, Gosney J, Field JK: LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus. Hum Pathol 1999, 30:1508-1514
71. Fan C, Sheu D, Fan H, Hsu K, Allen Chang C, Chan E: Down-regulation of matrix Gla protein messenger RNA in human colorectal adenocarcinomas. Cancer Lett 2001, 165:63-69
72. Sheikh MS, Shao ZM, Chen JC, Fontana JA: Differential regulation of matrix Gla protein (MGP) gene expression by retinoic acid and estrogen in human breast carcinoma cells. Mol Cell Endocrinol 1993, 92:153-160
73. Levedakou EN, Strohmeyer TG, Effert PJ, Liu ET: Expression of the matrix Gla protein in urogenital malignancies. Int J Cancer 1992, 52:534-537